Osi Pharmaceuticals Inc

Indentures Filter

EX-4.1
from 8-K 6 pages Amendment No. 1 to Rights Agreement
12/34/56
EX-4.3
from 8-K 21 pages Registration Rights Agreement Dated as of January 9, 2008 Among Osi Pharmaceuticals, Inc. and Merrill Lynch & Co., Merrill Lynch, Pierce, Fenner & Smith Incorporated and J.P. Morgan Securities Inc. Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 119 pages Osi Pharmaceuticals, Inc., as Issuer, and the Bank of New York, as Trustee Indenture Dated as of January 9, 2008 3% Convertible Senior Subordinated Notes Due 2038
12/34/56
EX-4.2
from S-8 22 pages Rules of the Osi Pharmaceuticals Savings-Related Share Option Scheme
12/34/56
EX-4.3
from 8-K 21 pages Registration Rights Agreement
12/34/56
EX-4.1
from 8-K 110 pages Osi Pharmaceuticals, Inc. 2% Convertible Senior Subordinated Notes Due 2025 Indenture Dated as of December 21, 2005 the Bank of New York as Trustee
12/34/56
EX-4.3
from S-8 12 pages Osi Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan
12/34/56
EX-4.2
from S-8 14 pages Osi Pharmaceuticals, Inc. Stock Plan for Assumed Options of Pre-Merger Employees of Eyetech Pharmaceuticals, Inc
12/34/56
EX-4.1
from S-8 9 pages Osi Pharmaceuticals, Inc. Stock Incentive Plan for Pre-Merger Employees of Eyetech Pharmaceuticals, Inc
12/34/56
EX-4.2
from S-3 ~20 pages Ex-4.2: Form of Deed of Share Exchange
12/34/56
EX-4.1
from S-3 ~20 pages Ex-4.1: Form of Deed of Share Exchange
12/34/56
EX-4.5
from S-3 ~5 pages Account Control Agreement
12/34/56
EX-4.4
from S-3 ~20 pages Collateral Pledge and Security Agreement
12/34/56
EX-4.11
from 10-K ~20 pages Registration Rights Agreements
12/34/56
EX-4.9
from 10-K >50 pages Indenture or similar
12/34/56
EX-4.2
from S-8 ~10 pages 2001 Incentive and Non-Qualified Stock Option Plan
12/34/56
EX-4.1
from S-8 ~10 pages Non-Qualified Stock Option Plan
12/34/56
EX-4.5
from S-3 ~5 pages Indenture or similar
12/34/56
EX-4.4
from S-3 ~20 pages Indenture or similar
12/34/56
EX-4.3
from S-3 ~20 pages Indenture or similar
12/34/56